kabutan

Kohjin Bio, First Half Ordinary Profit Decreases by 35%, Jul-Sep Ordinary Profit Decreases by 18%

Thu Nov 13, 2025 3:30 pm JST Earnings

177A Kohjin Bio Co.,Ltd. 【J-GAAP】

Earnings Report

Kohjin Bio Co.,Ltd. <177A> [TSE Growth] announced its financial results after the market closed on November 13th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) dropped 34.6% from the same period last year to 0.27 billion yen. Progress toward the full-year plan of 1.13 billion yen was 24.0%, also falling below the same period of the previous year of 39.1%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to expand 33.0% from the same period last year, reaching 0.86 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit decreased to 0.15 billion yen, an 18.3% decrease compared to the same period last year. The operating profit margin decreased from 13.7% in the same period last year to 9.8%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2024 2,507 379 416 277 55.7 39.1 Nov 14, 2024 J-GAAP
Apr - Sep, 2025 2,504 257 272 202 39.5 24.0 Nov 13, 2025 J-GAAP
YoY -0.1% -32.2% -34.6% -27.1% -29.0%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 14, 2025 J-GAAP
Apr - Sep, 2025 Results 2,504 257 272 202 39.5 0 Nov 13, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 2,699 612 649 517 102.6 24 May 14, 2025 J-GAAP
Oct - Mar, 2025 Guidance 3,175 808 863 620 121.3 25 Nov 13, 2025 J-GAAP
YoY +17.6% +32.0% +33.0% +19.9% +18.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 4,770 596 635 384 92.4 14 May 15, 2024 J-GAAP
Mar, 2025 5,206 991 1,065 794 157.6 24 May 14, 2025 J-GAAP
Mar, 2026 Guidance 5,679 1,065 1,135 822 160.8 25 May 14, 2025 J-GAAP
YoY +9.1% +7.5% +6.6% +3.5% +2.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 1,266 173 191 115 23.1 13.7 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 1,416 296 324 239 47.7 20.9 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 1,283 316 325 278 55.2 24.6 May 14, 2025 J-GAAP
Apr - Jun, 2025 1,219 131 116 82 16.1 10.7 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 1,285 126 156 120 23.5 9.8 Nov 13, 2025 J-GAAP
YoY +1.5% -27.2% -18.3% +4.3% +1.6%

Related Articles